The Nominating and Corporate Governance Committee oversees the preparation and periodically review of a diversity policy for the Board of Directors' approval. The Nominating and Corporate Governance Committee also administers and oversees all aspects of our corporate governance and corporate social responsibility (CSR) and makes recommendations to the Board of Directors regarding corporate governance, CSR and ESG issues. The Nominating and Corporate Governance Committee also oversees climate related financial risks and opportunities and Genmab's climate strategy, progress toward carbon reduction targets, and relevant prevention and mitigation measures. [...] The Nominating and Corporate Governance Committee Charter prescribes that this committee shall, among other things, evaluate, at least annually, (i) the size, performance, authority, operations, charter and composition of the Executive Management and the Board of Directors, including each standing board committee and (ii) the performance of each Executive Management, Board of Directors and committee member and (iii) recommend to the Board of Directors any changes considered appropriate in the size, authority, operations, charter or composition of the Executive Management, the Board of Directors and the committees. [...] The Nominating and Corporate Governance Committee also administers and oversees corporate governance and CSR and makes recommendations to the Board of Directors regarding corporate governance, CSR and ESG issues. The Nominating and Corporate Governance Committee also oversees climate related financial risks and opportunities and Genmab's climate strategy, progress toward carbon reduction targets, and relevant prevention and mitigation measures.